Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biotech Gwth (BIOG) Share Price

Price 1,626.00p on 29-07-2026 at 18:35:09
Change -16.00p -0.97%
Buy 1,634.00p
Sell 1,624.00p
Last Trade: Buy 20,000.00 at 1,658.00p
Day's Volume: 53,384
Last Close: 1,626.00p
Open: 1,656.00p
ISIN: GB0000385517
Day's Range 1,626.00p - 1,662.00p
52wk Range: 804.00p - 1,676.00p
Market Capitalisation: £310.69m
VWAP: 1,653.13551p
Shares in Issue: 19.11m

Biotech Gwth (BIOG) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 20,000 1,658.00p Suspected BUY Trade
16:36:32 - 29-Jul-26
Sell* 1,006 1,626.00p Uncrossing Trade
16:35:08 - 29-Jul-26
Buy* 322 1,629.125p Ordinary
16:28:47 - 29-Jul-26
Unknown* 0 1,622.00p SI Trade
16:27:40 - 29-Jul-26
Buy* 305 1,638.40p Ordinary
16:22:52 - 29-Jul-26
Sell* 12 1,618.00p SI Trade
16:20:12 - 29-Jul-26
Unknown* 0 1,642.00p SI Trade
16:12:42 - 29-Jul-26
Buy* 5 1,638.00p SI Trade
16:05:30 - 29-Jul-26
Buy* 60 1,636.40p Ordinary
16:03:53 - 29-Jul-26
Buy* 304 1,636.40p Ordinary
16:02:28 - 29-Jul-26
See more Biotech Gwth trades

Biotech Gwth (BIOG) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Jul 2026 (Wed) 1,656.00 1,662.00 1,626.00 1,626.00 53,384
28th Jul 2026 (Tue) 1,642.00 1,670.00 1,622.00 1,642.00 57,154
27th Jul 2026 (Mon) 1,614.00 1,676.00 1,614.00 1,658.00 75,836
24th Jul 2026 (Fri) 1,604.00 1,636.00 1,598.00 1,624.00 89,523
23rd Jul 2026 (Thu) 1,602.00 1,618.00 1,586.00 1,612.00 22,046
22nd Jul 2026 (Wed) 1,626.00 1,626.00 1,594.00 1,610.00 41,906
21st Jul 2026 (Tue) 1,576.00 1,614.00 1,564.00 1,608.00 34,238
20th Jul 2026 (Mon) 1,584.00 1,604.00 1,582.00 1,598.00 41,347
17th Jul 2026 (Fri) 1,578.00 1,600.00 1,578.00 1,594.00 87,039
16th Jul 2026 (Thu) 1,584.00 1,610.00 1,572.00 1,604.00 55,615
15th Jul 2026 (Wed) 1,580.00 1,596.00 1,572.00 1,590.00 49,119
14th Jul 2026 (Tue) 1,602.00 1,614.00 1,560.00 1,600.00 29,644
13th Jul 2026 (Mon) 1,632.00 1,642.00 1,582.00 1,616.00 53,825
10th Jul 2026 (Fri) 1,620.00 1,620.00 1,604.00 1,618.00 124,508
9th Jul 2026 (Thu) 1,618.00 1,650.00 1,618.00 1,640.00 32,734
8th Jul 2026 (Wed) 1,590.00 1,608.00 1,584.00 1,592.00 71,620
7th Jul 2026 (Tue) 1,546.00 1,586.00 1,542.00 1,584.00 64,606
6th Jul 2026 (Mon) 1,554.00 1,574.00 1,540.00 1,556.00 64,556
3rd Jul 2026 (Fri) 1,554.00 1,568.00 1,554.00 1,562.00 24,604
2nd Jul 2026 (Thu) 1,534.00 1,560.00 1,528.00 1,550.00 121,233
1st Jul 2026 (Wed) 1,578.00 1,582.00 1,534.00 1,558.00 84,703
30th Jun 2026 (Tue) 1,540.00 1,586.00 1,540.00 1,582.00 150,112
See more Biotech Gwth price history

Biotech Gwth (BIOG) Regulatory News

Date Source Headline
29th Jul 2026 3:11 pm PRN Net Asset Value(s)
28th Jul 2026 1:23 pm PRN Net Asset Value(s)
28th Jul 2026 7:00 am PRN argenx SE to acquire BIOG portfolio company, Forte Biosciences, Inc
27th Jul 2026 2:42 pm PRN Net Asset Value(s)
24th Jul 2026 5:13 pm PRN Transaction in Own Shares
24th Jul 2026 2:06 pm PRN Net Asset Value(s)
23rd Jul 2026 12:19 pm PRN Net Asset Value(s)
22nd Jul 2026 4:08 pm PRN Net Asset Value(s)
21st Jul 2026 1:37 pm PRN Net Asset Value(s)
20th Jul 2026 2:47 pm PRN Net Asset Value(s)
See more Biotech Gwth regulatory news

Biotech Gwth (BIOG) Share News

EARNINGS AND TRADING: Allergy Therapeutics names next executive chair

28th Jul 2026 13:36

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Biotech Growth says AtaiBeckley set for Eli Lilly takeover

17th Jul 2026 14:31

Biotech Growth Trust PLC - London-based investment trust - Eli Lilly & Co intends to acquire portfolio company AtaiBeckley Inc for approximately USD2.8 billion, or USD6.75 per share, in cash. This represents a 26% premium to AtaiBeckley's closing price on Wednesday. The offer also includes up to USD1 billion in contingent value rights linked to development and regulatory milestones, taking the potential value to USD3.8 billion, or USD9.25 per share, a 73% premium. AtaiBeckley is a clinical-stage biotechnology company focused on developing drugs to treat psychiatric disorders. BIOG says its AtaiBeckley holding accounted for 1.1% of its net asset value at the time of the announcement, and the transaction will be reflected in its Thursday NAV. Says this deal is the latest in a series of successful portfolio takeovers this year. Most recently, in May, French private equity firm ArchiMed SAS agreed to acquire investee Esperion Therapeutics. Read More

LONDON BRIEFING: Burberry US sales boost turnaround; Wise revenue up

17th Jul 2026 07:53

(Alliance News) - Burberry returns to first-quarter sales growth and raises its wholesale revenue guidance. Read More

EARNINGS AND TRADING: Vaultz Capital ousts CEO Benz, promotes Wood

3rd Jun 2026 19:08

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

See more Biotech Gwth news
FTSE 100 Latest
Value10,908.41
Change37.39

Login to your account

Forgot Password?

Not Registered